Share prices for medtech companies grew drastically in 2014. An article via MDDIonline.com explains that “Large companies saw their share prices grow, with Covidien’s share price growing the most. Even as the Irish company bid goodbye to the markets as a...
Lily Yang Vice President & Corporate Controller GILEAD SCIENCES Lily Yang serves as vice president, corporate controller of Gilead Sciences. In this role, she leads a team of 45 professionals in the U.S., Europe and Asia, providing financial and business...
Peter Pfreundschuh VP, Finance & Chief Financial Officer IMMUNOMEDICS Peter will be one of the distinguished speakers at the 7th Semi-Annual Life Science Financial Forum. Why are the 6th & 7th Semi-Annual Life Science Financial Forums important...
“The Emergency Care Research Institute (ECRI Institute) has released its annual ‘Top 10 Patient Safety Concerns for Healthcare Organizations,’ naming some repeat offenders—like device reprocessing—to the list and welcoming new additions like IV line...
After a three-year trial, Medtronic is touting positive results for the EverFlex self-expanding stent for treating peripheral artery disease it acquired when it bought Covidien for $50 billion, according to MassDevice.com. “The global medical device giant said...
